Senior Biomaterials Product Developer
Key Skills
Job Description
Kuros Biosciences, a Swiss-listed life science company with a Bilthoven site, is seeking a Senior Product Development Engineer to lead the development of bone void fillers and orthobiologics from concept through design transfer and commercial launch. The role blends hands-on engineering with biomaterials expertise, guiding cross-functional teams, maintaining DHF, and ensuring regulatory and manufacturing readiness for scalable products.
Core Responsibilities
Lead the development of bone void fillers and orthobiologics from concept through design transfer and commercial launch. Apply hands-on engineering and biomaterials expertise while guiding cross-functional teams and maintaining the Design History File (DHF), ensuring regulatory and manufacturing readiness for scalable products.
Requirements
The role calls for senior-level product development experience and expertise in biomaterials and orthobiologics. It also requires the ability to lead cross-functional teams and support design transfer, DHF maintenance, and regulatory and manufacturing readiness.
About Kuros Biosciences
Industry: Medical Equipment Manufacturing
Company size: 51-200 employees
OUR PURPOSE Kuros Biosciences is on a mission to discover, develop and deliver innovative biologic technologies. OUR CREDENTIALS Kuros is a Swiss-headquartered biotech company, listed on the SIX Swiss Stock Exchange since 2016 (under symbol KURN). With additional operations in the Netherlands and the USA, we continue to grow our global team. To deliver the ideal bone graft, you need the highest quality and quantity of scientific evidence behind it. We believe that this is a key differentiator for Kuros, given the urgent need to advance bone healing. • Listing on the 𝗦𝗜𝗫 𝗦𝘄𝗶𝘀𝘀 𝗘𝘅𝗰𝗵𝗮𝗻𝗴𝗲 under the symbol KURN since 2016 • A commercial & research footprint that spans >𝟮𝟬 𝗺𝗮𝗿𝗸𝗲𝘁𝘀 • Dozens of 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗻𝗱 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗲𝘅𝗽𝗲𝗿𝘁 𝗮𝗱𝘃𝗶𝘀𝗲𝗿𝘀 • >𝟮𝟱 orthobiologics-related 𝗽𝗮𝘁𝗲𝗻𝘁𝘀 • >𝟰𝟬𝟬 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲𝗱 in Level I, randomized controlled clinical trials • >𝟮𝟬 well-controlled 𝗟𝗲𝘃𝗲𝗹 𝗜-𝗜𝗩 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗲𝗱, including 6 that are complete¹ • Published Level I evidence published in 𝑆𝑝𝑖𝑛𝑒 CONTACT KUROS TO FIND OUT MORE >>>>